Literature DB >> 31392149

Prognostic impact of tumor infiltrating lymphocytes in bladder urothelial carcinoma.

Hyung Suk Kim1, Ja Hyeon Ku2.   

Abstract

Entities:  

Year:  2019        PMID： 31392149      PMCID： PMC6642954          DOI： 10.21037/tau.2019.04.02

Source DB:  PubMed          Journal:  Transl Androl Urol        ISSN： 2223-4683


× No keyword cloud information.
  9 in total

1.  High CD4⁺ T cell density is associated with poor prognosis in patients with non-muscle-invasive bladder cancer.

Authors:  Qinglei Zhang; Chongli Hao; Guangzhou Cheng; Lei Wang; Xiang Wang; Chang Li; Juhui Qiu; Kejia Ding
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

2.  Infiltration of CD3⁺ and CD68⁺ cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors.

Authors:  Gottfrid Sjödahl; Kristina Lövgren; Martin Lauss; Gunilla Chebil; Oliver Patschan; Sigurdur Gudjonsson; Wiking Månsson; Mårten Fernö; Karin Leandersson; David Lindgren; Fredrik Liedberg; Mattias Höglund
Journal:  Urol Oncol       Date:  2014-04-29       Impact factor: 3.498

3.  The prognostic effect of tumour-infiltrating lymphocytic subpopulations in bladder cancer.

Authors:  T Horn; J Laus; A K Seitz; T Maurer; S C Schmid; P Wolf; B Haller; M Winkler; M Retz; R Nawroth; J E Gschwend; H R Kübler; J Slotta-Huspenina
Journal:  World J Urol       Date:  2015-06-09       Impact factor: 4.226

4.  Assessment of tumoral PD-L1 expression and intratumoral CD8+ T cells in urothelial carcinoma.

Authors:  Sheila F Faraj; Enrico Munari; Gunes Guner; Janis Taube; Robert Anders; Jessica Hicks; Alan Meeker; Mark Schoenberg; Trinity Bivalacqua; Charles Drake; George J Netto
Journal:  Urology       Date:  2015-03       Impact factor: 2.649

5.  CD103+ Tumor Infiltrating Lymphocytes Predict a Favorable Prognosis in Urothelial Cell Carcinoma of the Bladder.

Authors:  Bo Wang; Shaoxu Wu; Hong Zeng; Zhuowei Liu; Wen Dong; Wang He; Xu Chen; Xiaoliang Dong; Limin Zheng; Tianxin Lin; Jian Huang
Journal:  J Urol       Date:  2015-03-06       Impact factor: 7.450

6.  Correlation of tumor-infiltrating lymphocytes with bladder cancer recurrence in patients with solitary low-grade urothelial carcinoma.

Authors:  Kristian Krpina; Emina Babarović; Nives Jonjić
Journal:  Virchows Arch       Date:  2015-07-28       Impact factor: 4.064

7.  Programmed death ligand-1 is associated with tumor infiltrating lymphocytes and poorer survival in urothelial cell carcinoma of the bladder.

Authors:  Bo Wang; Wenwei Pan; Meihua Yang; Wenjuan Yang; Wang He; Xu Chen; Junming Bi; Ning Jiang; Jian Huang; Tianxin Lin
Journal:  Cancer Sci       Date:  2018-12-12       Impact factor: 6.716

8.  Prognostic impact of tumor infiltrating lymphocytes on patients with metastatic urothelial carcinoma receiving platinum based chemotherapy.

Authors:  Hui-Shan Huang; Harvey Yu-Li Su; Pei-Hsu Li; Po-Hui Chiang; Cheng-Hua Huang; Chien-Hsu Chen; Meng-Che Hsieh
Journal:  Sci Rep       Date:  2018-05-10       Impact factor: 4.379

9.  Presence of lymphocytic infiltrate cytotoxic T lymphocyte CD3+, CD8+, and immunoscore as prognostic marker in patients after radical cystectomy.

Authors:  Alice Yu; Jose Joao Mansure; Shraddha Solanki; D Robert Siemens; Madhuri Koti; Ana B T Dias; Miguel M Burnier; Fadi Brimo; Wassim Kassouf
Journal:  PLoS One       Date:  2018-10-11       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.